Cargando…
Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort Study
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is suggested as a novel factor associated with coronary artery disease (CAD). However, few studies have comprehensively evaluated plasma PCSK9 with cardiovascular risk till now. Hence, we aimed to prospectively investigate the association between...
Autores principales: | Li, Jian-Jun, Li, Sha, Zhang, Yan, Xu, Rui-Xia, Guo, Yuan-Lin, Zhu, Cheng-Gang, Wu, Na-Qiong, Qing, Ping, Gao, Ying, Sun, Jing, Liu, Geng, Dong, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291644/ https://www.ncbi.nlm.nih.gov/pubmed/26717403 http://dx.doi.org/10.1097/MD.0000000000002426 |
Ejemplares similares
-
Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review
por: Wu, Na-Qiong, et al.
Publicado: (2022) -
High circulating proprotein convertase subtilisin/Kexin type 9 concentration associates with cardiovascular risk: A meta-analysis of cohort studies
por: Qiu, Chengfeng, et al.
Publicado: (2017) -
Variations of the proprotein convertase subtilisin/kexin type 9 gene
in coronary artery disease
por: Chiang, Shih-Min, et al.
Publicado: (2019) -
Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9
por: Melendez, Quantil M., et al.
Publicado: (2020) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017)